: The present invention relates to controlled release dosage form comprising Anti-Alzheimers drug. More particularly, the present invention relates to controlled release dosage form of galantamine or its salts. The present invention also relates to a process for the preparation of controlled release formulations of galantamine or its salts. No. of Pages : 21 No. of Claims : 10